Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Operating expenses:
Research and development expenses	$ 1,834,371	$ 194,068	$ 4,751,308	$ 563,812
General and administrative expenses	3,068,581	516,202	9,358,429	1,450,429
Lease termination costs	944,445	0	944,445	0
Total operating expenses	5,847,397	710,270	15,054,182	2,014,241
Loss from operations	(5,847,397)	(710,270)	(15,054,182)	(2,014,241)
Other income (expense):
Gain on bargain purchase upon merger	0	0	11,939,331	0
Interest income	95,787	4	294,694	14
Interest expense	0	(942)	(606)	(2,705)
Net loss	(5,751,610)	(711,208)	(2,820,763)	(2,016,932)
Comprehensive loss	$ (5,751,610)	$ (711,208)	$ (2,820,763)	$ (2,016,932)
Net loss per share, basic and diluted (in dollars per share)	$ (1.10)	$ (0.21)	$ (0.60)	$ (0.62)
Weighted average common shares outstanding, basic and diluted (in shares)	5,246,829	3,346,237	4,729,153	3,253,085